Both gene amplification and allelic loss occur at 14q13.3 in lung cancer

Clinical Cancer Research

Volumn 17, Issue 4, 2011, Pages 690-699

  Harris, Thomas ^a   Pan, Qiulu ^a   Sironi, Juan ^c   Lutz, Dionne ^a   Tian, Jianmin ^a   Sapkar, Jana ^a   Perez Soler, Roman ^a   Keller, Steven ^b   Locker, Joseph ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MBIP PROTEIN; MESSENGER RNA; PROTEIN; SFTA PROTEIN; TRANSCRIPTION FACTOR NKX2.1; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR NKX2.8; TRANSCRIPTION FACTOR PAX9; TTF1 PROTEIN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 14Q; CHROMOSOME 14Q13.3; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; BASE SEQUENCE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 14; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENETIC ASSOCIATION STUDIES; HOMEODOMAIN PROTEINS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 79951847988     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1892     Document Type: Article

References (28)

1. Warburton D, Wuenschell C, Flores-Delgado G, Anderson K. Commitment and differentiation of lung cell lineages. Biochem Cell Biol 1998;76:971-95. (Pubitemid 29450565)
2. Yuan B, Li C, Kimura S, Engelhardt RT, Smith BR, Minoo P. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn 2000;217:180-90. (Pubitemid 30080497)
3. Tian J, Mahmood R, Hnasko R, Locker J. Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia. Cancer Res 2006;66:10399-407. (Pubitemid 44799760)
4. Hofmann HS, Bartling B, Simm A, Murray R, Aziz N, Hansen G, et al. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59,620-element oligonucleotide array. Oncol Rep 2006;16:587-95.
5. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A 2007;104:16663-8. (Pubitemid 350211073)
6. Anagnostou VK, Syrigos KN, Bepler G, Homer RJ, Rimm DL. Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma. J Clin Oncol 2009;27:271-8.
7. Perner S, Wagner P, Soltermann A, Lafargue C, Tischler V, Weir B, et al. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 2009;217:65-72.
8. Kajiyama Y, Tian J, Locker J. Regulation of α-fetoprotein expression by Nkx2.8. Mol Cell Biol 2002;22:6122-30.
9. Wert SE, Dey CR, Blair PA, Kimura S, Whitsett JA. Increased expression of thyroid transcription factor-1 (TTF-1) in respiratory epithelial cells inhibits alveolarization and causes pulmonary inflammation. Dev Biol 2002;242:75-87. (Pubitemid 34163972)
10. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-35. (Pubitemid 40806415)
11. Apergis GA, Crawford N, Ghosh D, Steppan CM, Vorachek WR, Wen P, et al. A novel nk-2-related transcription factor associated with human fetal liver and hepatocellular carcinoma. J Biol Chem 1998;273:2917-25. (Pubitemid 28133942)
12. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60:4894-906.
13. Abujiang P, Mori TJ, Takahashi T, Tanaka F, Kasyu I, Hitomi S, et al. Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 1998;17:3029-33. (Pubitemid 29012206)
14. Shen H, Zhu Y, Wu YJ, Qiu HR, Shu YQ. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization. Cancer Genet Cytogenet 2008;181:100-7. (Pubitemid 351273421)
15. Hiai H, Abujiang P, Nishimura M. Polygenic resistance to mouse pulmonary adenomas. Exp Lung Res 2000;26:617-25. (Pubitemid 32044580)
16. Kwong FM, Wong PS, Lung ML. Genetic alterations detected on chromosomes 13 and 14 in Chinese non-small cell lung carcinomas. Cancer Lett 2003;192:189-98. (Pubitemid 36369273)
17. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008;27:3635-40. (Pubitemid 351793793)
18. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450:893-8. (Pubitemid 350231325)
19. McDaid HM, Lopez-Barcons L, Grossman A, Lia M, Keller S, Perez-Soler R, et al. Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants. Cancer Res 2005;65:2854-60. (Pubitemid 40490089)
20. Falzon M, McMahon JB, Gazdar AF, Schuller HM. Preferential metabolism of N-nitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomas. Carcinogenesis 1986;7:17-22. (Pubitemid 16184814)
21. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976;17:62-70.
22. Giaccone G, Battey J, Gazdar AF, Oie H, Draoui M, Moody TW. Neuromedin B is present in lung cancer cell lines. Cancer Res 1992;52:2732s-6s.
23. O'Reilly MA, Gazdar AF, Morris RE, Whitsett JA. Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta 1988;970:194-204.
24. Banks-Schlegel SP, Gazdar AF, Harris CC. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Cancer Res 1985;45:1187-97. (Pubitemid 15111281)
25. Vorachek WR, Steppan CM, Lima M, Black H, Bhattacharya R, Wen P, et al. Distant enhancers stimulate the albumin promoter through complex proximal binding sites. J Biol Chem 2000;275:29031-41.
26. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990;18:3587-96.
27. Martins SJ, Takagaki TY, Silva AG, Gallo CP, Silva FB, Capelozzi VL. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma. Lung Cancer 2009;64:105-9.
28. Yang L, Han Y, Suarez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia 2007;21:868-76. (Pubitemid 46672061)